Statement re: Announcement by Recipharm AB
2009年12月16日 - 11:02PM
RNSを含む英国規制内ニュース (英語)
TIDMCBF
RNS Number : 2295E
Cobra Bio-Manufacturing PLC
16 December 2009
+-------------------------------------+-------------------------------------+
| For Immediate Release | 16 December 2009 |
+-------------------------------------+-------------------------------------+
Cobra Biomanufacturing Plc ("Cobra" or "the Group" or "the Company")
Re Announcement by Recipharm AB ("Recipharm")
The Board of Cobra Biomanufacturing Plc, notes the announcement issued today by
Recipharm in relation to a mandatory cash offer for the Company at 2.25p per
ordinary share.
Trading conditions have remained very challenging with the continued delay in
the achievement of contract signatures and as a result the Company does not have
sufficient working capital for its current purposes. However, in accordance with
the City Code, it is envisaged that Recipharm will loan monies on normal
commercial terms to Cobra, in order for Cobra to meet its working capital
requirements during the integration of the Recipharm and Cobra businesses.
A further announcement will be made in due course.
For further information, please contact:
+------------------------------------------------+--------------------------+
| Cobra Biomanufacturing Plc | Tel: +44 (0) 1782 714 |
| | 181 |
+------------------------------------------------+--------------------------+
| Danny Chapchal, Chairman | |
+------------------------------------------------+--------------------------+
| Simon Saxby, Chief Executive | |
+------------------------------------------------+--------------------------+
| Peter Coleman, Finance Director | |
+------------------------------------------------+--------------------------+
| | |
+------------------------------------------------+--------------------------+
| Buchanan Communications | Tel: +44 (0) 207 466 |
| | 5000 |
+------------------------------------------------+--------------------------+
| Tim Anderson | |
+------------------------------------------------+--------------------------+
| | |
+------------------------------------------------+--------------------------+
| Seymour Pierce (NOMAD & Broker) | Tel: +44 (0) 20 107 8000 |
+------------------------------------------------+--------------------------+
| Chris Howard | |
+------------------------------------------------+--------------------------+
| Christopher Wren | |
+------------------------------------------------+--------------------------+
This information is provided by RNS
The company news service from the London Stock Exchange
END
STRUNRSRKRRUAAA
Cobra Bio-manufacturing (LSE:CBF)
過去 株価チャート
から 5 2024 まで 6 2024
Cobra Bio-manufacturing (LSE:CBF)
過去 株価チャート
から 6 2023 まで 6 2024
Real-Time news about Cobra Bio-Man. (ロンドン証券取引所): 0 recent articles
その他のCobra Bio-manufacturingニュース記事